Letter to the editor: Reduced doses of systemic thrombolysis in acute pulmonary embolism

Angiology. 2024 Mar;75(3):297-298. doi: 10.1177/00033197231184050. Epub 2023 Jun 17.

Authors

Mateo Porres-Aguilar¹, Parth Rali², Ka U Lio³, Belinda Rivera-Lebron⁴

Affiliations

¹ Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.
² Department of Thoracic Medicine and Surgery, Temple University Hospital, Philadelphia, PA, USA.
³ Department of Internal Medicine, Temple University Hospital, Philadelphia, PA, USA.
⁴ Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

PMID: 37329335
DOI: 10.1177/00033197231184050

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
Fibrinolytic Agents / adverse effects
Humans
Pulmonary Embolism* / drug therapy
Thrombolytic Therapy / adverse effects
Treatment Outcome

Substances

Fibrinolytic Agents